Clinical trials
Terminated Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
926 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 6 |
| 2002 | 10 |
| 2003 | 14 |
| 2004 | 21 |
| 2005 | 23 |
| 2006 | 36 |
| 2007 | 54 |
| 2008 | 47 |
| 2009 | 41 |
| 2010 | 37 |
| 2011 | 33 |
| 2012 | 29 |
| 2013 | 27 |
| 2014 | 30 |
| 2015 | 68 |
| 2016 | 43 |
| 2017 | 49 |
| 2018 | 62 |
| 2019 | 49 |
| 2020 | 49 |
| 2021 | 64 |
| 2022 | 51 |
| 2023 | 40 |
| 2024 | 27 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 926 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 34 |
| National Cancer Institute (NCI) | 32 |
| Novartis Pharmaceuticals | 25 |
| Merck Sharp & Dohme LLC | 16 |
| M.D. Anderson Cancer Center | 15 |
| AstraZeneca | 14 |
| GlaxoSmithKline | 11 |
| Hoffmann-La Roche | 10 |
| Incyte Corporation | 10 |
| Vanderbilt-Ingram Cancer Center | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 926 |
| Lung Neoplasms | 226 |
| Melanoma | 88 |
| Colorectal Neoplasms | 78 |
| Neoplasm Metastasis | 78 |
| Neoplasms | 69 |
| Squamous Cell Carcinoma of Head and Neck | 59 |
| Ovarian Neoplasms | 56 |
| Carcinoma, Renal Cell | 54 |
| Breast Neoplasms | 48 |
Trials
Showing 1 to 25 of 926. Each trial links to its page on Pharma Observatory.
826 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.